Global CD34+ Cell Selection Equipment Market Growth 2026-2032
The global CD34+ Cell Selection Equipment market size is predicted to grow from US$ 80.73 million in 2025 to US$ 149 million in 2032; it is expected to grow at a CAGR of 9.0% from 2026 to 2032.
CD34+ cell selection equipment refers to instruments used to perform the separation, enrichment, or selection of CD34+ hematopoietic stem and progenitor cells. The core function of this type of equipment is to obtain enriched CD34+ cell populations from complex samples such as bone marrow, cord blood, mobilized peripheral blood, leukapheresis products, or PBMCs through hardware-based processes including anti-CD34 labeling systems, magnetic separation, column-based separation, column-free separation, or bag-based magnetic separation.
From an industrial positioning perspective, CD34+ cell selection equipment is located at the intersection of life science instruments, cell therapy manufacturing equipment, and hematopoietic stem cell transplantation support equipment. Its main uses include clinical graft processing, research-grade CD34+ cell separation, cell therapy process development, sample processing before gene editing, and GMP-grade cell preparation workflows. Technological development is moving from early manual magnetic racks and open manual operations toward closed, automated, traceable, high-throughput, and GMP-compatible equipment systems. In the current market, the number of equipment suppliers is significantly smaller than the number of reagent and consumable suppliers. Global equipment supply is mainly concentrated among Miltenyi Biotec, STEMCELL Technologies, Applied Cells, and a small number of magnetic separation device suppliers. Compared with kits and magnetic beads, the equipment market is smaller in scale and has lower purchase frequency, but the value per unit is higher, customer validation cycles are longer, and barriers to entry are also higher. The upstream segment of this type of equipment mainly includes magnet components, precision pumps and valves, fluidic control modules, sensors, touchscreens and embedded control systems, disposable tubing adaptation structures, electromechanical integrated components, quality management systems, and GMP validation capabilities. The reliability of upstream equipment directly affects cell recovery rate, cell viability, batch-to-batch consistency, sterility assurance, and process traceability. Downstream customers mainly include hematopoietic stem cell transplantation centers, hematology and oncology departments, cell therapy companies, gene-editing therapy companies, cell process development laboratories, CROs, CDMOs, and large research institutions. Downstream demand is not equivalent to the total number of hematopoietic stem cell transplantations, because only some transplantation and cell therapy workflows require CD34+ cell selection equipment. Nevertheless, HCT and cell therapy activities still form an important demand base. The EBMT report shows that HCT activity in Europe and surrounding regions reached 47,731 cases in 2023, with allogeneic HCT increasing by 7.8% year on year and CAR-T therapy increasing by 52.5%, indicating that transplantation and advanced cell therapy activities are still expanding. In terms of policy, the U.S. FDA has approved the CliniMACS CD34 Reagent System for specific AML patient settings, and gene therapy products based on enriched CD34+ cell populations, such as CASGEVY, have also been approved. These developments are increasing the importance of clinical-grade, closed, and verifiable cell processing equipment. Future trends in pricing, production volume, and market size will differ from those of reagents and consumables. Equipment prices are unlikely to decline rapidly like ordinary consumables, because their value mainly comes from hardware reliability, software control, closed processing workflows, GMP compatibility, after-sales service, validation documentation, and customer process lock-in. However, research-grade automated separators and semi-automated magnetic separation devices may experience gradual unit price declines due to intensified competition and domestic substitution. In terms of production volume, annual shipments of clinical-grade closed equipment will continue to show the characteristics of small batches and high unit prices, while shipments of research-grade automation equipment and process development equipment are expected to grow faster, mainly driven by cell therapy process development, CD34+ gene-editing research, and laboratory automation demand. This market is not a large-scale consumables market, but a small-scale, high-barrier specialized equipment market that is gradually expanding alongside the automation of cell therapy manufacturing.
LP Information, Inc. (LPI) ' newest research report, the ?CD34+ Cell Selection Equipment Industry Forecast? looks at past sales and reviews total world CD34+ Cell Selection Equipment sales in 2025, providing a comprehensive analysis by region and market sector of projected CD34+ Cell Selection Equipment sales for 2026 through 2032. With CD34+ Cell Selection Equipment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world CD34+ Cell Selection Equipment industry.
This Insight Report provides a comprehensive analysis of the global CD34+ Cell Selection Equipment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on CD34+ Cell Selection Equipment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global CD34+ Cell Selection Equipment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for CD34+ Cell Selection Equipment and breaks down the forecast by Technology Route, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global CD34+ Cell Selection Equipment.
This report presents a comprehensive overview, market shares, and growth opportunities of CD34+ Cell Selection Equipment market by product type, application, key manufacturers and key regions and countries.
Segmentation by Technology Route:
What is the 10-year outlook for the global CD34+ Cell Selection Equipment market?
What factors are driving CD34+ Cell Selection Equipment market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do CD34+ Cell Selection Equipment market opportunities vary by end market size?
How does CD34+ Cell Selection Equipment break out by Technology Route, by Application?
CD34+ cell selection equipment refers to instruments used to perform the separation, enrichment, or selection of CD34+ hematopoietic stem and progenitor cells. The core function of this type of equipment is to obtain enriched CD34+ cell populations from complex samples such as bone marrow, cord blood, mobilized peripheral blood, leukapheresis products, or PBMCs through hardware-based processes including anti-CD34 labeling systems, magnetic separation, column-based separation, column-free separation, or bag-based magnetic separation.
From an industrial positioning perspective, CD34+ cell selection equipment is located at the intersection of life science instruments, cell therapy manufacturing equipment, and hematopoietic stem cell transplantation support equipment. Its main uses include clinical graft processing, research-grade CD34+ cell separation, cell therapy process development, sample processing before gene editing, and GMP-grade cell preparation workflows. Technological development is moving from early manual magnetic racks and open manual operations toward closed, automated, traceable, high-throughput, and GMP-compatible equipment systems. In the current market, the number of equipment suppliers is significantly smaller than the number of reagent and consumable suppliers. Global equipment supply is mainly concentrated among Miltenyi Biotec, STEMCELL Technologies, Applied Cells, and a small number of magnetic separation device suppliers. Compared with kits and magnetic beads, the equipment market is smaller in scale and has lower purchase frequency, but the value per unit is higher, customer validation cycles are longer, and barriers to entry are also higher. The upstream segment of this type of equipment mainly includes magnet components, precision pumps and valves, fluidic control modules, sensors, touchscreens and embedded control systems, disposable tubing adaptation structures, electromechanical integrated components, quality management systems, and GMP validation capabilities. The reliability of upstream equipment directly affects cell recovery rate, cell viability, batch-to-batch consistency, sterility assurance, and process traceability. Downstream customers mainly include hematopoietic stem cell transplantation centers, hematology and oncology departments, cell therapy companies, gene-editing therapy companies, cell process development laboratories, CROs, CDMOs, and large research institutions. Downstream demand is not equivalent to the total number of hematopoietic stem cell transplantations, because only some transplantation and cell therapy workflows require CD34+ cell selection equipment. Nevertheless, HCT and cell therapy activities still form an important demand base. The EBMT report shows that HCT activity in Europe and surrounding regions reached 47,731 cases in 2023, with allogeneic HCT increasing by 7.8% year on year and CAR-T therapy increasing by 52.5%, indicating that transplantation and advanced cell therapy activities are still expanding. In terms of policy, the U.S. FDA has approved the CliniMACS CD34 Reagent System for specific AML patient settings, and gene therapy products based on enriched CD34+ cell populations, such as CASGEVY, have also been approved. These developments are increasing the importance of clinical-grade, closed, and verifiable cell processing equipment. Future trends in pricing, production volume, and market size will differ from those of reagents and consumables. Equipment prices are unlikely to decline rapidly like ordinary consumables, because their value mainly comes from hardware reliability, software control, closed processing workflows, GMP compatibility, after-sales service, validation documentation, and customer process lock-in. However, research-grade automated separators and semi-automated magnetic separation devices may experience gradual unit price declines due to intensified competition and domestic substitution. In terms of production volume, annual shipments of clinical-grade closed equipment will continue to show the characteristics of small batches and high unit prices, while shipments of research-grade automation equipment and process development equipment are expected to grow faster, mainly driven by cell therapy process development, CD34+ gene-editing research, and laboratory automation demand. This market is not a large-scale consumables market, but a small-scale, high-barrier specialized equipment market that is gradually expanding alongside the automation of cell therapy manufacturing.
LP Information, Inc. (LPI) ' newest research report, the ?CD34+ Cell Selection Equipment Industry Forecast? looks at past sales and reviews total world CD34+ Cell Selection Equipment sales in 2025, providing a comprehensive analysis by region and market sector of projected CD34+ Cell Selection Equipment sales for 2026 through 2032. With CD34+ Cell Selection Equipment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world CD34+ Cell Selection Equipment industry.
This Insight Report provides a comprehensive analysis of the global CD34+ Cell Selection Equipment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on CD34+ Cell Selection Equipment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global CD34+ Cell Selection Equipment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for CD34+ Cell Selection Equipment and breaks down the forecast by Technology Route, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global CD34+ Cell Selection Equipment.
This report presents a comprehensive overview, market shares, and growth opportunities of CD34+ Cell Selection Equipment market by product type, application, key manufacturers and key regions and countries.
Segmentation by Technology Route:
- Column-Based Immunomagnetic Selection
- Column-Free Immunomagnetic Selection
- Buoyancy-Activated Microbubble Sorting
- Closed Clinical System
- Laboratory Selection Kit
- Platform-Based Selection Instrument
- Direct Positive Selection
- Direct Negative Enrichment
- Pre-Enrichment Followed By Positive Selection
- Clinical Transplant Cell Preparation
- Research-Use Cell Isolation
- Process Development And Translational Research
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Miltenyi Biotec GmbH
- STEMCELL Technologies Inc.
- Thermo Fisher Scientific Inc.
- Applied Cells, Inc.
- Akadeum Life Sciences, Inc.
- Bio-Techne Corporation
- Revvity, Inc.
- GenScript Biotech Corporation
- Beaver Biomedical Engineering Co., Ltd.
- Suzhou Xinxie Biotechnology Co., Ltd.
- APExBIO Technology LLC
What is the 10-year outlook for the global CD34+ Cell Selection Equipment market?
What factors are driving CD34+ Cell Selection Equipment market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do CD34+ Cell Selection Equipment market opportunities vary by end market size?
How does CD34+ Cell Selection Equipment break out by Technology Route, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global CD34+ Cell Selection Equipment Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for CD34+ Cell Selection Equipment by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for CD34+ Cell Selection Equipment by Country/Region, 2021, 2025 & 2032
2.2 CD34+ Cell Selection Equipment Segment by Technology Route
2.2.1 Column-Based Immunomagnetic Selection
2.2.2 Column-Free Immunomagnetic Selection
2.2.3 Buoyancy-Activated Microbubble Sorting
2.2.4 CD34+ Cell Selection Equipment Sales by Technology Route
2.2.4.1 Global CD34+ Cell Selection Equipment Sales Market Share by Technology Route (2021-2026)
2.2.4.2 Global CD34+ Cell Selection Equipment Revenue and Market Share by Technology Route (2021-2026)
2.2.4.3 Global CD34+ Cell Selection Equipment Sale Price by Technology Route (2021-2026)
2.3 CD34+ Cell Selection Equipment Segment by Product Delivery Form
2.3.1 Closed Clinical System
2.3.2 Laboratory Selection Kit
2.3.3 Platform-Based Selection Instrument
2.3.4 CD34+ Cell Selection Equipment Sales by Product Delivery Form
2.3.4.1 Global CD34+ Cell Selection Equipment Sales Market Share by Product Delivery Form (2021-2026)
2.3.4.2 Global CD34+ Cell Selection Equipment Revenue and Market Share by Product Delivery Form (2021-2026)
2.3.4.3 Global CD34+ Cell Selection Equipment Sale Price by Product Delivery Form (2021-2026)
2.4 CD34+ Cell Selection Equipment Segment by CD34+ Cell Acquisition Workflow
2.4.1 Direct Positive Selection
2.4.2 Direct Negative Enrichment
2.4.3 Pre-Enrichment Followed By Positive Selection
2.4.4 CD34+ Cell Selection Equipment Sales by CD34+ Cell Acquisition Workflow
2.4.4.1 Global CD34+ Cell Selection Equipment Sales Market Share by CD34+ Cell Acquisition Workflow (2021-2026)
2.4.4.2 Global CD34+ Cell Selection Equipment Revenue and Market Share by CD34+ Cell Acquisition Workflow (2021-2026)
2.4.4.3 Global CD34+ Cell Selection Equipment Sale Price by CD34+ Cell Acquisition Workflow (2021-2026)
2.5 CD34+ Cell Selection Equipment Segment by Application
2.5.1 Clinical Transplant Cell Preparation
2.5.2 Research-Use Cell Isolation
2.5.3 Process Development And Translational Research
2.5.4 CD34+ Cell Selection Equipment Sales by Application
2.5.4.1 Global CD34+ Cell Selection Equipment Sale Market Share by Application (2021-2026)
2.5.4.2 Global CD34+ Cell Selection Equipment Revenue and Market Share by Application (2021-2026)
2.5.4.3 Global CD34+ Cell Selection Equipment Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global CD34+ Cell Selection Equipment Breakdown Data by Company
3.1.1 Global CD34+ Cell Selection Equipment Annual Sales by Company (2021-2026)
3.1.2 Global CD34+ Cell Selection Equipment Sales Market Share by Company (2021-2026)
3.2 Global CD34+ Cell Selection Equipment Annual Revenue by Company (2021-2026)
3.2.1 Global CD34+ Cell Selection Equipment Revenue by Company (2021-2026)
3.2.2 Global CD34+ Cell Selection Equipment Revenue Market Share by Company (2021-2026)
3.3 Global CD34+ Cell Selection Equipment Sale Price by Company
3.4 Key Manufacturers CD34+ Cell Selection Equipment Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers CD34+ Cell Selection Equipment Product Location Distribution
3.4.2 Players CD34+ Cell Selection Equipment Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR CD34+ CELL SELECTION EQUIPMENT BY GEOGRAPHIC REGION
4.1 World Historic CD34+ Cell Selection Equipment Market Size by Geographic Region (2021-2026)
4.1.1 Global CD34+ Cell Selection Equipment Annual Sales by Geographic Region (2021-2026)
4.1.2 Global CD34+ Cell Selection Equipment Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic CD34+ Cell Selection Equipment Market Size by Country/Region (2021-2026)
4.2.1 Global CD34+ Cell Selection Equipment Annual Sales by Country/Region (2021-2026)
4.2.2 Global CD34+ Cell Selection Equipment Annual Revenue by Country/Region (2021-2026)
4.3 Americas CD34+ Cell Selection Equipment Sales Growth
4.4 APAC CD34+ Cell Selection Equipment Sales Growth
4.5 Europe CD34+ Cell Selection Equipment Sales Growth
4.6 Middle East & Africa CD34+ Cell Selection Equipment Sales Growth
5 AMERICAS
5.1 Americas CD34+ Cell Selection Equipment Sales by Country
5.1.1 Americas CD34+ Cell Selection Equipment Sales by Country (2021-2026)
5.1.2 Americas CD34+ Cell Selection Equipment Revenue by Country (2021-2026)
5.2 Americas CD34+ Cell Selection Equipment Sales by Technology Route (2021-2026)
5.3 Americas CD34+ Cell Selection Equipment Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC CD34+ Cell Selection Equipment Sales by Region
6.1.1 APAC CD34+ Cell Selection Equipment Sales by Region (2021-2026)
6.1.2 APAC CD34+ Cell Selection Equipment Revenue by Region (2021-2026)
6.2 APAC CD34+ Cell Selection Equipment Sales by Technology Route (2021-2026)
6.3 APAC CD34+ Cell Selection Equipment Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe CD34+ Cell Selection Equipment by Country
7.1.1 Europe CD34+ Cell Selection Equipment Sales by Country (2021-2026)
7.1.2 Europe CD34+ Cell Selection Equipment Revenue by Country (2021-2026)
7.2 Europe CD34+ Cell Selection Equipment Sales by Technology Route (2021-2026)
7.3 Europe CD34+ Cell Selection Equipment Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa CD34+ Cell Selection Equipment by Country
8.1.1 Middle East & Africa CD34+ Cell Selection Equipment Sales by Country (2021-2026)
8.1.2 Middle East & Africa CD34+ Cell Selection Equipment Revenue by Country (2021-2026)
8.2 Middle East & Africa CD34+ Cell Selection Equipment Sales by Technology Route (2021-2026)
8.3 Middle East & Africa CD34+ Cell Selection Equipment Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of CD34+ Cell Selection Equipment
10.3 Manufacturing Process Analysis of CD34+ Cell Selection Equipment
10.4 Industry Chain Structure of CD34+ Cell Selection Equipment
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 CD34+ Cell Selection Equipment Distributors
11.3 CD34+ Cell Selection Equipment Customer
12 WORLD FORECAST REVIEW FOR CD34+ CELL SELECTION EQUIPMENT BY GEOGRAPHIC REGION
12.1 Global CD34+ Cell Selection Equipment Market Size Forecast by Region
12.1.1 Global CD34+ Cell Selection Equipment Forecast by Region (2027-2032)
12.1.2 Global CD34+ Cell Selection Equipment Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global CD34+ Cell Selection Equipment Forecast by Technology Route (2027-2032)
12.7 Global CD34+ Cell Selection Equipment Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Miltenyi Biotec GmbH
13.1.1 Miltenyi Biotec GmbH Company Information
13.1.2 Miltenyi Biotec GmbH CD34+ Cell Selection Equipment Product Portfolios and Specifications
13.1.3 Miltenyi Biotec GmbH CD34+ Cell Selection Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Miltenyi Biotec GmbH Main Business Overview
13.1.5 Miltenyi Biotec GmbH Latest Developments
13.2 STEMCELL Technologies Inc.
13.2.1 STEMCELL Technologies Inc. Company Information
13.2.2 STEMCELL Technologies Inc. CD34+ Cell Selection Equipment Product Portfolios and Specifications
13.2.3 STEMCELL Technologies Inc. CD34+ Cell Selection Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 STEMCELL Technologies Inc. Main Business Overview
13.2.5 STEMCELL Technologies Inc. Latest Developments
13.3 Thermo Fisher Scientific Inc.
13.3.1 Thermo Fisher Scientific Inc. Company Information
13.3.2 Thermo Fisher Scientific Inc. CD34+ Cell Selection Equipment Product Portfolios and Specifications
13.3.3 Thermo Fisher Scientific Inc. CD34+ Cell Selection Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Thermo Fisher Scientific Inc. Main Business Overview
13.3.5 Thermo Fisher Scientific Inc. Latest Developments
13.4 Applied Cells, Inc.
13.4.1 Applied Cells, Inc. Company Information
13.4.2 Applied Cells, Inc. CD34+ Cell Selection Equipment Product Portfolios and Specifications
13.4.3 Applied Cells, Inc. CD34+ Cell Selection Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Applied Cells, Inc. Main Business Overview
13.4.5 Applied Cells, Inc. Latest Developments
13.5 Akadeum Life Sciences, Inc.
13.5.1 Akadeum Life Sciences, Inc. Company Information
13.5.2 Akadeum Life Sciences, Inc. CD34+ Cell Selection Equipment Product Portfolios and Specifications
13.5.3 Akadeum Life Sciences, Inc. CD34+ Cell Selection Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Akadeum Life Sciences, Inc. Main Business Overview
13.5.5 Akadeum Life Sciences, Inc. Latest Developments
13.6 Bio-Techne Corporation
13.6.1 Bio-Techne Corporation Company Information
13.6.2 Bio-Techne Corporation CD34+ Cell Selection Equipment Product Portfolios and Specifications
13.6.3 Bio-Techne Corporation CD34+ Cell Selection Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Bio-Techne Corporation Main Business Overview
13.6.5 Bio-Techne Corporation Latest Developments
13.7 Revvity, Inc.
13.7.1 Revvity, Inc. Company Information
13.7.2 Revvity, Inc. CD34+ Cell Selection Equipment Product Portfolios and Specifications
13.7.3 Revvity, Inc. CD34+ Cell Selection Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Revvity, Inc. Main Business Overview
13.7.5 Revvity, Inc. Latest Developments
13.8 GenScript Biotech Corporation
13.8.1 GenScript Biotech Corporation Company Information
13.8.2 GenScript Biotech Corporation CD34+ Cell Selection Equipment Product Portfolios and Specifications
13.8.3 GenScript Biotech Corporation CD34+ Cell Selection Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 GenScript Biotech Corporation Main Business Overview
13.8.5 GenScript Biotech Corporation Latest Developments
13.9 Beaver Biomedical Engineering Co., Ltd.
13.9.1 Beaver Biomedical Engineering Co., Ltd. Company Information
13.9.2 Beaver Biomedical Engineering Co., Ltd. CD34+ Cell Selection Equipment Product Portfolios and Specifications
13.9.3 Beaver Biomedical Engineering Co., Ltd. CD34+ Cell Selection Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Beaver Biomedical Engineering Co., Ltd. Main Business Overview
13.9.5 Beaver Biomedical Engineering Co., Ltd. Latest Developments
13.10 Suzhou Xinxie Biotechnology Co., Ltd.
13.10.1 Suzhou Xinxie Biotechnology Co., Ltd. Company Information
13.10.2 Suzhou Xinxie Biotechnology Co., Ltd. CD34+ Cell Selection Equipment Product Portfolios and Specifications
13.10.3 Suzhou Xinxie Biotechnology Co., Ltd. CD34+ Cell Selection Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Suzhou Xinxie Biotechnology Co., Ltd. Main Business Overview
13.10.5 Suzhou Xinxie Biotechnology Co., Ltd. Latest Developments
13.11 APExBIO Technology LLC
13.11.1 APExBIO Technology LLC Company Information
13.11.2 APExBIO Technology LLC CD34+ Cell Selection Equipment Product Portfolios and Specifications
13.11.3 APExBIO Technology LLC CD34+ Cell Selection Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 APExBIO Technology LLC Main Business Overview
13.11.5 APExBIO Technology LLC Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global CD34+ Cell Selection Equipment Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for CD34+ Cell Selection Equipment by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for CD34+ Cell Selection Equipment by Country/Region, 2021, 2025 & 2032
2.2 CD34+ Cell Selection Equipment Segment by Technology Route
2.2.1 Column-Based Immunomagnetic Selection
2.2.2 Column-Free Immunomagnetic Selection
2.2.3 Buoyancy-Activated Microbubble Sorting
2.2.4 CD34+ Cell Selection Equipment Sales by Technology Route
2.2.4.1 Global CD34+ Cell Selection Equipment Sales Market Share by Technology Route (2021-2026)
2.2.4.2 Global CD34+ Cell Selection Equipment Revenue and Market Share by Technology Route (2021-2026)
2.2.4.3 Global CD34+ Cell Selection Equipment Sale Price by Technology Route (2021-2026)
2.3 CD34+ Cell Selection Equipment Segment by Product Delivery Form
2.3.1 Closed Clinical System
2.3.2 Laboratory Selection Kit
2.3.3 Platform-Based Selection Instrument
2.3.4 CD34+ Cell Selection Equipment Sales by Product Delivery Form
2.3.4.1 Global CD34+ Cell Selection Equipment Sales Market Share by Product Delivery Form (2021-2026)
2.3.4.2 Global CD34+ Cell Selection Equipment Revenue and Market Share by Product Delivery Form (2021-2026)
2.3.4.3 Global CD34+ Cell Selection Equipment Sale Price by Product Delivery Form (2021-2026)
2.4 CD34+ Cell Selection Equipment Segment by CD34+ Cell Acquisition Workflow
2.4.1 Direct Positive Selection
2.4.2 Direct Negative Enrichment
2.4.3 Pre-Enrichment Followed By Positive Selection
2.4.4 CD34+ Cell Selection Equipment Sales by CD34+ Cell Acquisition Workflow
2.4.4.1 Global CD34+ Cell Selection Equipment Sales Market Share by CD34+ Cell Acquisition Workflow (2021-2026)
2.4.4.2 Global CD34+ Cell Selection Equipment Revenue and Market Share by CD34+ Cell Acquisition Workflow (2021-2026)
2.4.4.3 Global CD34+ Cell Selection Equipment Sale Price by CD34+ Cell Acquisition Workflow (2021-2026)
2.5 CD34+ Cell Selection Equipment Segment by Application
2.5.1 Clinical Transplant Cell Preparation
2.5.2 Research-Use Cell Isolation
2.5.3 Process Development And Translational Research
2.5.4 CD34+ Cell Selection Equipment Sales by Application
2.5.4.1 Global CD34+ Cell Selection Equipment Sale Market Share by Application (2021-2026)
2.5.4.2 Global CD34+ Cell Selection Equipment Revenue and Market Share by Application (2021-2026)
2.5.4.3 Global CD34+ Cell Selection Equipment Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global CD34+ Cell Selection Equipment Breakdown Data by Company
3.1.1 Global CD34+ Cell Selection Equipment Annual Sales by Company (2021-2026)
3.1.2 Global CD34+ Cell Selection Equipment Sales Market Share by Company (2021-2026)
3.2 Global CD34+ Cell Selection Equipment Annual Revenue by Company (2021-2026)
3.2.1 Global CD34+ Cell Selection Equipment Revenue by Company (2021-2026)
3.2.2 Global CD34+ Cell Selection Equipment Revenue Market Share by Company (2021-2026)
3.3 Global CD34+ Cell Selection Equipment Sale Price by Company
3.4 Key Manufacturers CD34+ Cell Selection Equipment Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers CD34+ Cell Selection Equipment Product Location Distribution
3.4.2 Players CD34+ Cell Selection Equipment Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR CD34+ CELL SELECTION EQUIPMENT BY GEOGRAPHIC REGION
4.1 World Historic CD34+ Cell Selection Equipment Market Size by Geographic Region (2021-2026)
4.1.1 Global CD34+ Cell Selection Equipment Annual Sales by Geographic Region (2021-2026)
4.1.2 Global CD34+ Cell Selection Equipment Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic CD34+ Cell Selection Equipment Market Size by Country/Region (2021-2026)
4.2.1 Global CD34+ Cell Selection Equipment Annual Sales by Country/Region (2021-2026)
4.2.2 Global CD34+ Cell Selection Equipment Annual Revenue by Country/Region (2021-2026)
4.3 Americas CD34+ Cell Selection Equipment Sales Growth
4.4 APAC CD34+ Cell Selection Equipment Sales Growth
4.5 Europe CD34+ Cell Selection Equipment Sales Growth
4.6 Middle East & Africa CD34+ Cell Selection Equipment Sales Growth
5 AMERICAS
5.1 Americas CD34+ Cell Selection Equipment Sales by Country
5.1.1 Americas CD34+ Cell Selection Equipment Sales by Country (2021-2026)
5.1.2 Americas CD34+ Cell Selection Equipment Revenue by Country (2021-2026)
5.2 Americas CD34+ Cell Selection Equipment Sales by Technology Route (2021-2026)
5.3 Americas CD34+ Cell Selection Equipment Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC CD34+ Cell Selection Equipment Sales by Region
6.1.1 APAC CD34+ Cell Selection Equipment Sales by Region (2021-2026)
6.1.2 APAC CD34+ Cell Selection Equipment Revenue by Region (2021-2026)
6.2 APAC CD34+ Cell Selection Equipment Sales by Technology Route (2021-2026)
6.3 APAC CD34+ Cell Selection Equipment Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe CD34+ Cell Selection Equipment by Country
7.1.1 Europe CD34+ Cell Selection Equipment Sales by Country (2021-2026)
7.1.2 Europe CD34+ Cell Selection Equipment Revenue by Country (2021-2026)
7.2 Europe CD34+ Cell Selection Equipment Sales by Technology Route (2021-2026)
7.3 Europe CD34+ Cell Selection Equipment Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa CD34+ Cell Selection Equipment by Country
8.1.1 Middle East & Africa CD34+ Cell Selection Equipment Sales by Country (2021-2026)
8.1.2 Middle East & Africa CD34+ Cell Selection Equipment Revenue by Country (2021-2026)
8.2 Middle East & Africa CD34+ Cell Selection Equipment Sales by Technology Route (2021-2026)
8.3 Middle East & Africa CD34+ Cell Selection Equipment Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of CD34+ Cell Selection Equipment
10.3 Manufacturing Process Analysis of CD34+ Cell Selection Equipment
10.4 Industry Chain Structure of CD34+ Cell Selection Equipment
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 CD34+ Cell Selection Equipment Distributors
11.3 CD34+ Cell Selection Equipment Customer
12 WORLD FORECAST REVIEW FOR CD34+ CELL SELECTION EQUIPMENT BY GEOGRAPHIC REGION
12.1 Global CD34+ Cell Selection Equipment Market Size Forecast by Region
12.1.1 Global CD34+ Cell Selection Equipment Forecast by Region (2027-2032)
12.1.2 Global CD34+ Cell Selection Equipment Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global CD34+ Cell Selection Equipment Forecast by Technology Route (2027-2032)
12.7 Global CD34+ Cell Selection Equipment Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Miltenyi Biotec GmbH
13.1.1 Miltenyi Biotec GmbH Company Information
13.1.2 Miltenyi Biotec GmbH CD34+ Cell Selection Equipment Product Portfolios and Specifications
13.1.3 Miltenyi Biotec GmbH CD34+ Cell Selection Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Miltenyi Biotec GmbH Main Business Overview
13.1.5 Miltenyi Biotec GmbH Latest Developments
13.2 STEMCELL Technologies Inc.
13.2.1 STEMCELL Technologies Inc. Company Information
13.2.2 STEMCELL Technologies Inc. CD34+ Cell Selection Equipment Product Portfolios and Specifications
13.2.3 STEMCELL Technologies Inc. CD34+ Cell Selection Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 STEMCELL Technologies Inc. Main Business Overview
13.2.5 STEMCELL Technologies Inc. Latest Developments
13.3 Thermo Fisher Scientific Inc.
13.3.1 Thermo Fisher Scientific Inc. Company Information
13.3.2 Thermo Fisher Scientific Inc. CD34+ Cell Selection Equipment Product Portfolios and Specifications
13.3.3 Thermo Fisher Scientific Inc. CD34+ Cell Selection Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Thermo Fisher Scientific Inc. Main Business Overview
13.3.5 Thermo Fisher Scientific Inc. Latest Developments
13.4 Applied Cells, Inc.
13.4.1 Applied Cells, Inc. Company Information
13.4.2 Applied Cells, Inc. CD34+ Cell Selection Equipment Product Portfolios and Specifications
13.4.3 Applied Cells, Inc. CD34+ Cell Selection Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Applied Cells, Inc. Main Business Overview
13.4.5 Applied Cells, Inc. Latest Developments
13.5 Akadeum Life Sciences, Inc.
13.5.1 Akadeum Life Sciences, Inc. Company Information
13.5.2 Akadeum Life Sciences, Inc. CD34+ Cell Selection Equipment Product Portfolios and Specifications
13.5.3 Akadeum Life Sciences, Inc. CD34+ Cell Selection Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Akadeum Life Sciences, Inc. Main Business Overview
13.5.5 Akadeum Life Sciences, Inc. Latest Developments
13.6 Bio-Techne Corporation
13.6.1 Bio-Techne Corporation Company Information
13.6.2 Bio-Techne Corporation CD34+ Cell Selection Equipment Product Portfolios and Specifications
13.6.3 Bio-Techne Corporation CD34+ Cell Selection Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Bio-Techne Corporation Main Business Overview
13.6.5 Bio-Techne Corporation Latest Developments
13.7 Revvity, Inc.
13.7.1 Revvity, Inc. Company Information
13.7.2 Revvity, Inc. CD34+ Cell Selection Equipment Product Portfolios and Specifications
13.7.3 Revvity, Inc. CD34+ Cell Selection Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Revvity, Inc. Main Business Overview
13.7.5 Revvity, Inc. Latest Developments
13.8 GenScript Biotech Corporation
13.8.1 GenScript Biotech Corporation Company Information
13.8.2 GenScript Biotech Corporation CD34+ Cell Selection Equipment Product Portfolios and Specifications
13.8.3 GenScript Biotech Corporation CD34+ Cell Selection Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 GenScript Biotech Corporation Main Business Overview
13.8.5 GenScript Biotech Corporation Latest Developments
13.9 Beaver Biomedical Engineering Co., Ltd.
13.9.1 Beaver Biomedical Engineering Co., Ltd. Company Information
13.9.2 Beaver Biomedical Engineering Co., Ltd. CD34+ Cell Selection Equipment Product Portfolios and Specifications
13.9.3 Beaver Biomedical Engineering Co., Ltd. CD34+ Cell Selection Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Beaver Biomedical Engineering Co., Ltd. Main Business Overview
13.9.5 Beaver Biomedical Engineering Co., Ltd. Latest Developments
13.10 Suzhou Xinxie Biotechnology Co., Ltd.
13.10.1 Suzhou Xinxie Biotechnology Co., Ltd. Company Information
13.10.2 Suzhou Xinxie Biotechnology Co., Ltd. CD34+ Cell Selection Equipment Product Portfolios and Specifications
13.10.3 Suzhou Xinxie Biotechnology Co., Ltd. CD34+ Cell Selection Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Suzhou Xinxie Biotechnology Co., Ltd. Main Business Overview
13.10.5 Suzhou Xinxie Biotechnology Co., Ltd. Latest Developments
13.11 APExBIO Technology LLC
13.11.1 APExBIO Technology LLC Company Information
13.11.2 APExBIO Technology LLC CD34+ Cell Selection Equipment Product Portfolios and Specifications
13.11.3 APExBIO Technology LLC CD34+ Cell Selection Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 APExBIO Technology LLC Main Business Overview
13.11.5 APExBIO Technology LLC Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. CD34+ Cell Selection Equipment Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. CD34+ Cell Selection Equipment Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Column-Based Immunomagnetic Selection
Table 4. Major Players of Column-Free Immunomagnetic Selection
Table 5. Major Players of Buoyancy-Activated Microbubble Sorting
Table 6. Global CD34+ Cell Selection Equipment Sales by Technology Route (2021-2026) & (Units)
Table 7. Global CD34+ Cell Selection Equipment Sales Market Share by Technology Route (2021-2026)
Table 8. Global CD34+ Cell Selection Equipment Revenue by Technology Route (2021-2026) & ($ million)
Table 9. Global CD34+ Cell Selection Equipment Revenue Market Share by Technology Route (2021-2026)
Table 10. Global CD34+ Cell Selection Equipment Sale Price by Technology Route (2021-2026) & (US$/Unit)
Table 11. Major Players of Closed Clinical System
Table 12. Major Players of Laboratory Selection Kit
Table 13. Major Players of Platform-Based Selection Instrument
Table 14. Global CD34+ Cell Selection Equipment Sales by Product Delivery Form (2021-2026) & (Units)
Table 15. Global CD34+ Cell Selection Equipment Sales Market Share by Product Delivery Form (2021-2026)
Table 16. Global CD34+ Cell Selection Equipment Revenue by Product Delivery Form (2021-2026) & ($ million)
Table 17. Global CD34+ Cell Selection Equipment Revenue Market Share by Product Delivery Form (2021-2026)
Table 18. Global CD34+ Cell Selection Equipment Sale Price by Product Delivery Form (2021-2026) & (US$/Unit)
Table 19. Major Players of Direct Positive Selection
Table 20. Major Players of Direct Negative Enrichment
Table 21. Major Players of Pre-Enrichment Followed By Positive Selection
Table 22. Global CD34+ Cell Selection Equipment Sales by CD34+ Cell Acquisition Workflow (2021-2026) & (Units)
Table 23. Global CD34+ Cell Selection Equipment Sales Market Share by CD34+ Cell Acquisition Workflow (2021-2026)
Table 24. Global CD34+ Cell Selection Equipment Revenue by CD34+ Cell Acquisition Workflow (2021-2026) & ($ million)
Table 25. Global CD34+ Cell Selection Equipment Revenue Market Share by CD34+ Cell Acquisition Workflow (2021-2026)
Table 26. Global CD34+ Cell Selection Equipment Sale Price by CD34+ Cell Acquisition Workflow (2021-2026) & (US$/Unit)
Table 27. Global CD34+ Cell Selection Equipment Sale by Application (2021-2026) & (Units)
Table 28. Global CD34+ Cell Selection Equipment Sale Market Share by Application (2021-2026)
Table 29. Global CD34+ Cell Selection Equipment Revenue by Application (2021-2026) & ($ million)
Table 30. Global CD34+ Cell Selection Equipment Revenue Market Share by Application (2021-2026)
Table 31. Global CD34+ Cell Selection Equipment Sale Price by Application (2021-2026) & (US$/Unit)
Table 32. Global CD34+ Cell Selection Equipment Sales by Company (2021-2026) & (Units)
Table 33. Global CD34+ Cell Selection Equipment Sales Market Share by Company (2021-2026)
Table 34. Global CD34+ Cell Selection Equipment Revenue by Company (2021-2026) & ($ millions)
Table 35. Global CD34+ Cell Selection Equipment Revenue Market Share by Company (2021-2026)
Table 36. Global CD34+ Cell Selection Equipment Sale Price by Company (2021-2026) & (US$/Unit)
Table 37. Key Manufacturers CD34+ Cell Selection Equipment Producing Area Distribution and Sales Area
Table 38. Players CD34+ Cell Selection Equipment Products Offered
Table 39. CD34+ Cell Selection Equipment Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 40. New Products and Potential Entrants
Table 41. Market M&A Activity & Strategy
Table 42. Global CD34+ Cell Selection Equipment Sales by Geographic Region (2021-2026) & (Units)
Table 43. Global CD34+ Cell Selection Equipment Sales Market Share Geographic Region (2021-2026)
Table 44. Global CD34+ Cell Selection Equipment Revenue by Geographic Region (2021-2026) & ($ millions)
Table 45. Global CD34+ Cell Selection Equipment Revenue Market Share by Geographic Region (2021-2026)
Table 46. Global CD34+ Cell Selection Equipment Sales by Country/Region (2021-2026) & (Units)
Table 47. Global CD34+ Cell Selection Equipment Sales Market Share by Country/Region (2021-2026)
Table 48. Global CD34+ Cell Selection Equipment Revenue by Country/Region (2021-2026) & ($ millions)
Table 49. Global CD34+ Cell Selection Equipment Revenue Market Share by Country/Region (2021-2026)
Table 50. Americas CD34+ Cell Selection Equipment Sales by Country (2021-2026) & (Units)
Table 51. Americas CD34+ Cell Selection Equipment Sales Market Share by Country (2021-2026)
Table 52. Americas CD34+ Cell Selection Equipment Revenue by Country (2021-2026) & ($ millions)
Table 53. Americas CD34+ Cell Selection Equipment Sales by Technology Route (2021-2026) & (Units)
Table 54. Americas CD34+ Cell Selection Equipment Sales by Application (2021-2026) & (Units)
Table 55. APAC CD34+ Cell Selection Equipment Sales by Region (2021-2026) & (Units)
Table 56. APAC CD34+ Cell Selection Equipment Sales Market Share by Region (2021-2026)
Table 57. APAC CD34+ Cell Selection Equipment Revenue by Region (2021-2026) & ($ millions)
Table 58. APAC CD34+ Cell Selection Equipment Sales by Technology Route (2021-2026) & (Units)
Table 59. APAC CD34+ Cell Selection Equipment Sales by Application (2021-2026) & (Units)
Table 60. Europe CD34+ Cell Selection Equipment Sales by Country (2021-2026) & (Units)
Table 61. Europe CD34+ Cell Selection Equipment Revenue by Country (2021-2026) & ($ millions)
Table 62. Europe CD34+ Cell Selection Equipment Sales by Technology Route (2021-2026) & (Units)
Table 63. Europe CD34+ Cell Selection Equipment Sales by Application (2021-2026) & (Units)
Table 64. Middle East & Africa CD34+ Cell Selection Equipment Sales by Country (2021-2026) & (Units)
Table 65. Middle East & Africa CD34+ Cell Selection Equipment Revenue Market Share by Country (2021-2026)
Table 66. Middle East & Africa CD34+ Cell Selection Equipment Sales by Technology Route (2021-2026) & (Units)
Table 67. Middle East & Africa CD34+ Cell Selection Equipment Sales by Application (2021-2026) & (Units)
Table 68. Key Market Drivers & Growth Opportunities of CD34+ Cell Selection Equipment
Table 69. Key Market Challenges & Risks of CD34+ Cell Selection Equipment
Table 70. Key Industry Trends of CD34+ Cell Selection Equipment
Table 71. CD34+ Cell Selection Equipment Raw Material
Table 72. Key Suppliers of Raw Materials
Table 73. CD34+ Cell Selection Equipment Distributors List
Table 74. CD34+ Cell Selection Equipment Customer List
Table 75. Global CD34+ Cell Selection Equipment Sales Forecast by Region (2027-2032) & (Units)
Table 76. Global CD34+ Cell Selection Equipment Revenue Forecast by Region (2027-2032) & ($ millions)
Table 77. Americas CD34+ Cell Selection Equipment Sales Forecast by Country (2027-2032) & (Units)
Table 78. Americas CD34+ Cell Selection Equipment Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 79. APAC CD34+ Cell Selection Equipment Sales Forecast by Region (2027-2032) & (Units)
Table 80. APAC CD34+ Cell Selection Equipment Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 81. Europe CD34+ Cell Selection Equipment Sales Forecast by Country (2027-2032) & (Units)
Table 82. Europe CD34+ Cell Selection Equipment Revenue Forecast by Country (2027-2032) & ($ millions)
Table 83. Middle East & Africa CD34+ Cell Selection Equipment Sales Forecast by Country (2027-2032) & (Units)
Table 84. Middle East & Africa CD34+ Cell Selection Equipment Revenue Forecast by Country (2027-2032) & ($ millions)
Table 85. Global CD34+ Cell Selection Equipment Sales Forecast by Technology Route (2027-2032) & (Units)
Table 86. Global CD34+ Cell Selection Equipment Revenue Forecast by Technology Route (2027-2032) & ($ millions)
Table 87. Global CD34+ Cell Selection Equipment Sales Forecast by Application (2027-2032) & (Units)
Table 88. Global CD34+ Cell Selection Equipment Revenue Forecast by Application (2027-2032) & ($ millions)
Table 89. Miltenyi Biotec GmbH Basic Information, CD34+ Cell Selection Equipment Manufacturing Base, Sales Area and Its Competitors
Table 90. Miltenyi Biotec GmbH CD34+ Cell Selection Equipment Product Portfolios and Specifications
Table 91. Miltenyi Biotec GmbH CD34+ Cell Selection Equipment Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 92. Miltenyi Biotec GmbH Main Business
Table 93. Miltenyi Biotec GmbH Latest Developments
Table 94. STEMCELL Technologies Inc. Basic Information, CD34+ Cell Selection Equipment Manufacturing Base, Sales Area and Its Competitors
Table 95. STEMCELL Technologies Inc. CD34+ Cell Selection Equipment Product Portfolios and Specifications
Table 96. STEMCELL Technologies Inc. CD34+ Cell Selection Equipment Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 97. STEMCELL Technologies Inc. Main Business
Table 98. STEMCELL Technologies Inc. Latest Developments
Table 99. Thermo Fisher Scientific Inc. Basic Information, CD34+ Cell Selection Equipment Manufacturing Base, Sales Area and Its Competitors
Table 100. Thermo Fisher Scientific Inc. CD34+ Cell Selection Equipment Product Portfolios and Specifications
Table 101. Thermo Fisher Scientific Inc. CD34+ Cell Selection Equipment Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 102. Thermo Fisher Scientific Inc. Main Business
Table 103. Thermo Fisher Scientific Inc. Latest Developments
Table 104. Applied Cells, Inc. Basic Information, CD34+ Cell Selection Equipment Manufacturing Base, Sales Area and Its Competitors
Table 105. Applied Cells, Inc. CD34+ Cell Selection Equipment Product Portfolios and Specifications
Table 106. Applied Cells, Inc. CD34+ Cell Selection Equipment Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 107. Applied Cells, Inc. Main Business
Table 108. Applied Cells, Inc. Latest Developments
Table 109. Akadeum Life Sciences, Inc. Basic Information, CD34+ Cell Selection Equipment Manufacturing Base, Sales Area and Its Competitors
Table 110. Akadeum Life Sciences, Inc. CD34+ Cell Selection Equipment Product Portfolios and Specifications
Table 111. Akadeum Life Sciences, Inc. CD34+ Cell Selection Equipment Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 112. Akadeum Life Sciences, Inc. Main Business
Table 113. Akadeum Life Sciences, Inc. Latest Developments
Table 114. Bio-Techne Corporation Basic Information, CD34+ Cell Selection Equipment Manufacturing Base, Sales Area and Its Competitors
Table 115. Bio-Techne Corporation CD34+ Cell Selection Equipment Product Portfolios and Specifications
Table 116. Bio-Techne Corporation CD34+ Cell Selection Equipment Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 117. Bio-Techne Corporation Main Business
Table 118. Bio-Techne Corporation Latest Developments
Table 119. Revvity, Inc. Basic Information, CD34+ Cell Selection Equipment Manufacturing Base, Sales Area and Its Competitors
Table 120. Revvity, Inc. CD34+ Cell Selection Equipment Product Portfolios and Specifications
Table 121. Revvity, Inc. CD34+ Cell Selection Equipment Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 122. Revvity, Inc. Main Business
Table 123. Revvity, Inc. Latest Developments
Table 124. GenScript Biotech Corporation Basic Information, CD34+ Cell Selection Equipment Manufacturing Base, Sales Area and Its Competitors
Table 125. GenScript Biotech Corporation CD34+ Cell Selection Equipment Product Portfolios and Specifications
Table 126. GenScript Biotech Corporation CD34+ Cell Selection Equipment Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 127. GenScript Biotech Corporation Main Business
Table 128. GenScript Biotech Corporation Latest Developments
Table 129. Beaver Biomedical Engineering Co., Ltd. Basic Information, CD34+ Cell Selection Equipment Manufacturing Base, Sales Area and Its Competitors
Table 130. Beaver Biomedical Engineering Co., Ltd. CD34+ Cell Selection Equipment Product Portfolios and Specifications
Table 131. Beaver Biomedical Engineering Co., Ltd. CD34+ Cell Selection Equipment Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 132. Beaver Biomedical Engineering Co., Ltd. Main Business
Table 133. Beaver Biomedical Engineering Co., Ltd. Latest Developments
Table 134. Suzhou Xinxie Biotechnology Co., Ltd. Basic Information, CD34+ Cell Selection Equipment Manufacturing Base, Sales Area and Its Competitors
Table 135. Suzhou Xinxie Biotechnology Co., Ltd. CD34+ Cell Selection Equipment Product Portfolios and Specifications
Table 136. Suzhou Xinxie Biotechnology Co., Ltd. CD34+ Cell Selection Equipment Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 137. Suzhou Xinxie Biotechnology Co., Ltd. Main Business
Table 138. Suzhou Xinxie Biotechnology Co., Ltd. Latest Developments
Table 139. APExBIO Technology LLC Basic Information, CD34+ Cell Selection Equipment Manufacturing Base, Sales Area and Its Competitors
Table 140. APExBIO Technology LLC CD34+ Cell Selection Equipment Product Portfolios and Specifications
Table 141. APExBIO Technology LLC CD34+ Cell Selection Equipment Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 142. APExBIO Technology LLC Main Business
Table 143. APExBIO Technology LLC Latest Developments
Table 1. CD34+ Cell Selection Equipment Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. CD34+ Cell Selection Equipment Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Column-Based Immunomagnetic Selection
Table 4. Major Players of Column-Free Immunomagnetic Selection
Table 5. Major Players of Buoyancy-Activated Microbubble Sorting
Table 6. Global CD34+ Cell Selection Equipment Sales by Technology Route (2021-2026) & (Units)
Table 7. Global CD34+ Cell Selection Equipment Sales Market Share by Technology Route (2021-2026)
Table 8. Global CD34+ Cell Selection Equipment Revenue by Technology Route (2021-2026) & ($ million)
Table 9. Global CD34+ Cell Selection Equipment Revenue Market Share by Technology Route (2021-2026)
Table 10. Global CD34+ Cell Selection Equipment Sale Price by Technology Route (2021-2026) & (US$/Unit)
Table 11. Major Players of Closed Clinical System
Table 12. Major Players of Laboratory Selection Kit
Table 13. Major Players of Platform-Based Selection Instrument
Table 14. Global CD34+ Cell Selection Equipment Sales by Product Delivery Form (2021-2026) & (Units)
Table 15. Global CD34+ Cell Selection Equipment Sales Market Share by Product Delivery Form (2021-2026)
Table 16. Global CD34+ Cell Selection Equipment Revenue by Product Delivery Form (2021-2026) & ($ million)
Table 17. Global CD34+ Cell Selection Equipment Revenue Market Share by Product Delivery Form (2021-2026)
Table 18. Global CD34+ Cell Selection Equipment Sale Price by Product Delivery Form (2021-2026) & (US$/Unit)
Table 19. Major Players of Direct Positive Selection
Table 20. Major Players of Direct Negative Enrichment
Table 21. Major Players of Pre-Enrichment Followed By Positive Selection
Table 22. Global CD34+ Cell Selection Equipment Sales by CD34+ Cell Acquisition Workflow (2021-2026) & (Units)
Table 23. Global CD34+ Cell Selection Equipment Sales Market Share by CD34+ Cell Acquisition Workflow (2021-2026)
Table 24. Global CD34+ Cell Selection Equipment Revenue by CD34+ Cell Acquisition Workflow (2021-2026) & ($ million)
Table 25. Global CD34+ Cell Selection Equipment Revenue Market Share by CD34+ Cell Acquisition Workflow (2021-2026)
Table 26. Global CD34+ Cell Selection Equipment Sale Price by CD34+ Cell Acquisition Workflow (2021-2026) & (US$/Unit)
Table 27. Global CD34+ Cell Selection Equipment Sale by Application (2021-2026) & (Units)
Table 28. Global CD34+ Cell Selection Equipment Sale Market Share by Application (2021-2026)
Table 29. Global CD34+ Cell Selection Equipment Revenue by Application (2021-2026) & ($ million)
Table 30. Global CD34+ Cell Selection Equipment Revenue Market Share by Application (2021-2026)
Table 31. Global CD34+ Cell Selection Equipment Sale Price by Application (2021-2026) & (US$/Unit)
Table 32. Global CD34+ Cell Selection Equipment Sales by Company (2021-2026) & (Units)
Table 33. Global CD34+ Cell Selection Equipment Sales Market Share by Company (2021-2026)
Table 34. Global CD34+ Cell Selection Equipment Revenue by Company (2021-2026) & ($ millions)
Table 35. Global CD34+ Cell Selection Equipment Revenue Market Share by Company (2021-2026)
Table 36. Global CD34+ Cell Selection Equipment Sale Price by Company (2021-2026) & (US$/Unit)
Table 37. Key Manufacturers CD34+ Cell Selection Equipment Producing Area Distribution and Sales Area
Table 38. Players CD34+ Cell Selection Equipment Products Offered
Table 39. CD34+ Cell Selection Equipment Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 40. New Products and Potential Entrants
Table 41. Market M&A Activity & Strategy
Table 42. Global CD34+ Cell Selection Equipment Sales by Geographic Region (2021-2026) & (Units)
Table 43. Global CD34+ Cell Selection Equipment Sales Market Share Geographic Region (2021-2026)
Table 44. Global CD34+ Cell Selection Equipment Revenue by Geographic Region (2021-2026) & ($ millions)
Table 45. Global CD34+ Cell Selection Equipment Revenue Market Share by Geographic Region (2021-2026)
Table 46. Global CD34+ Cell Selection Equipment Sales by Country/Region (2021-2026) & (Units)
Table 47. Global CD34+ Cell Selection Equipment Sales Market Share by Country/Region (2021-2026)
Table 48. Global CD34+ Cell Selection Equipment Revenue by Country/Region (2021-2026) & ($ millions)
Table 49. Global CD34+ Cell Selection Equipment Revenue Market Share by Country/Region (2021-2026)
Table 50. Americas CD34+ Cell Selection Equipment Sales by Country (2021-2026) & (Units)
Table 51. Americas CD34+ Cell Selection Equipment Sales Market Share by Country (2021-2026)
Table 52. Americas CD34+ Cell Selection Equipment Revenue by Country (2021-2026) & ($ millions)
Table 53. Americas CD34+ Cell Selection Equipment Sales by Technology Route (2021-2026) & (Units)
Table 54. Americas CD34+ Cell Selection Equipment Sales by Application (2021-2026) & (Units)
Table 55. APAC CD34+ Cell Selection Equipment Sales by Region (2021-2026) & (Units)
Table 56. APAC CD34+ Cell Selection Equipment Sales Market Share by Region (2021-2026)
Table 57. APAC CD34+ Cell Selection Equipment Revenue by Region (2021-2026) & ($ millions)
Table 58. APAC CD34+ Cell Selection Equipment Sales by Technology Route (2021-2026) & (Units)
Table 59. APAC CD34+ Cell Selection Equipment Sales by Application (2021-2026) & (Units)
Table 60. Europe CD34+ Cell Selection Equipment Sales by Country (2021-2026) & (Units)
Table 61. Europe CD34+ Cell Selection Equipment Revenue by Country (2021-2026) & ($ millions)
Table 62. Europe CD34+ Cell Selection Equipment Sales by Technology Route (2021-2026) & (Units)
Table 63. Europe CD34+ Cell Selection Equipment Sales by Application (2021-2026) & (Units)
Table 64. Middle East & Africa CD34+ Cell Selection Equipment Sales by Country (2021-2026) & (Units)
Table 65. Middle East & Africa CD34+ Cell Selection Equipment Revenue Market Share by Country (2021-2026)
Table 66. Middle East & Africa CD34+ Cell Selection Equipment Sales by Technology Route (2021-2026) & (Units)
Table 67. Middle East & Africa CD34+ Cell Selection Equipment Sales by Application (2021-2026) & (Units)
Table 68. Key Market Drivers & Growth Opportunities of CD34+ Cell Selection Equipment
Table 69. Key Market Challenges & Risks of CD34+ Cell Selection Equipment
Table 70. Key Industry Trends of CD34+ Cell Selection Equipment
Table 71. CD34+ Cell Selection Equipment Raw Material
Table 72. Key Suppliers of Raw Materials
Table 73. CD34+ Cell Selection Equipment Distributors List
Table 74. CD34+ Cell Selection Equipment Customer List
Table 75. Global CD34+ Cell Selection Equipment Sales Forecast by Region (2027-2032) & (Units)
Table 76. Global CD34+ Cell Selection Equipment Revenue Forecast by Region (2027-2032) & ($ millions)
Table 77. Americas CD34+ Cell Selection Equipment Sales Forecast by Country (2027-2032) & (Units)
Table 78. Americas CD34+ Cell Selection Equipment Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 79. APAC CD34+ Cell Selection Equipment Sales Forecast by Region (2027-2032) & (Units)
Table 80. APAC CD34+ Cell Selection Equipment Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 81. Europe CD34+ Cell Selection Equipment Sales Forecast by Country (2027-2032) & (Units)
Table 82. Europe CD34+ Cell Selection Equipment Revenue Forecast by Country (2027-2032) & ($ millions)
Table 83. Middle East & Africa CD34+ Cell Selection Equipment Sales Forecast by Country (2027-2032) & (Units)
Table 84. Middle East & Africa CD34+ Cell Selection Equipment Revenue Forecast by Country (2027-2032) & ($ millions)
Table 85. Global CD34+ Cell Selection Equipment Sales Forecast by Technology Route (2027-2032) & (Units)
Table 86. Global CD34+ Cell Selection Equipment Revenue Forecast by Technology Route (2027-2032) & ($ millions)
Table 87. Global CD34+ Cell Selection Equipment Sales Forecast by Application (2027-2032) & (Units)
Table 88. Global CD34+ Cell Selection Equipment Revenue Forecast by Application (2027-2032) & ($ millions)
Table 89. Miltenyi Biotec GmbH Basic Information, CD34+ Cell Selection Equipment Manufacturing Base, Sales Area and Its Competitors
Table 90. Miltenyi Biotec GmbH CD34+ Cell Selection Equipment Product Portfolios and Specifications
Table 91. Miltenyi Biotec GmbH CD34+ Cell Selection Equipment Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 92. Miltenyi Biotec GmbH Main Business
Table 93. Miltenyi Biotec GmbH Latest Developments
Table 94. STEMCELL Technologies Inc. Basic Information, CD34+ Cell Selection Equipment Manufacturing Base, Sales Area and Its Competitors
Table 95. STEMCELL Technologies Inc. CD34+ Cell Selection Equipment Product Portfolios and Specifications
Table 96. STEMCELL Technologies Inc. CD34+ Cell Selection Equipment Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 97. STEMCELL Technologies Inc. Main Business
Table 98. STEMCELL Technologies Inc. Latest Developments
Table 99. Thermo Fisher Scientific Inc. Basic Information, CD34+ Cell Selection Equipment Manufacturing Base, Sales Area and Its Competitors
Table 100. Thermo Fisher Scientific Inc. CD34+ Cell Selection Equipment Product Portfolios and Specifications
Table 101. Thermo Fisher Scientific Inc. CD34+ Cell Selection Equipment Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 102. Thermo Fisher Scientific Inc. Main Business
Table 103. Thermo Fisher Scientific Inc. Latest Developments
Table 104. Applied Cells, Inc. Basic Information, CD34+ Cell Selection Equipment Manufacturing Base, Sales Area and Its Competitors
Table 105. Applied Cells, Inc. CD34+ Cell Selection Equipment Product Portfolios and Specifications
Table 106. Applied Cells, Inc. CD34+ Cell Selection Equipment Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 107. Applied Cells, Inc. Main Business
Table 108. Applied Cells, Inc. Latest Developments
Table 109. Akadeum Life Sciences, Inc. Basic Information, CD34+ Cell Selection Equipment Manufacturing Base, Sales Area and Its Competitors
Table 110. Akadeum Life Sciences, Inc. CD34+ Cell Selection Equipment Product Portfolios and Specifications
Table 111. Akadeum Life Sciences, Inc. CD34+ Cell Selection Equipment Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 112. Akadeum Life Sciences, Inc. Main Business
Table 113. Akadeum Life Sciences, Inc. Latest Developments
Table 114. Bio-Techne Corporation Basic Information, CD34+ Cell Selection Equipment Manufacturing Base, Sales Area and Its Competitors
Table 115. Bio-Techne Corporation CD34+ Cell Selection Equipment Product Portfolios and Specifications
Table 116. Bio-Techne Corporation CD34+ Cell Selection Equipment Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 117. Bio-Techne Corporation Main Business
Table 118. Bio-Techne Corporation Latest Developments
Table 119. Revvity, Inc. Basic Information, CD34+ Cell Selection Equipment Manufacturing Base, Sales Area and Its Competitors
Table 120. Revvity, Inc. CD34+ Cell Selection Equipment Product Portfolios and Specifications
Table 121. Revvity, Inc. CD34+ Cell Selection Equipment Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 122. Revvity, Inc. Main Business
Table 123. Revvity, Inc. Latest Developments
Table 124. GenScript Biotech Corporation Basic Information, CD34+ Cell Selection Equipment Manufacturing Base, Sales Area and Its Competitors
Table 125. GenScript Biotech Corporation CD34+ Cell Selection Equipment Product Portfolios and Specifications
Table 126. GenScript Biotech Corporation CD34+ Cell Selection Equipment Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 127. GenScript Biotech Corporation Main Business
Table 128. GenScript Biotech Corporation Latest Developments
Table 129. Beaver Biomedical Engineering Co., Ltd. Basic Information, CD34+ Cell Selection Equipment Manufacturing Base, Sales Area and Its Competitors
Table 130. Beaver Biomedical Engineering Co., Ltd. CD34+ Cell Selection Equipment Product Portfolios and Specifications
Table 131. Beaver Biomedical Engineering Co., Ltd. CD34+ Cell Selection Equipment Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 132. Beaver Biomedical Engineering Co., Ltd. Main Business
Table 133. Beaver Biomedical Engineering Co., Ltd. Latest Developments
Table 134. Suzhou Xinxie Biotechnology Co., Ltd. Basic Information, CD34+ Cell Selection Equipment Manufacturing Base, Sales Area and Its Competitors
Table 135. Suzhou Xinxie Biotechnology Co., Ltd. CD34+ Cell Selection Equipment Product Portfolios and Specifications
Table 136. Suzhou Xinxie Biotechnology Co., Ltd. CD34+ Cell Selection Equipment Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 137. Suzhou Xinxie Biotechnology Co., Ltd. Main Business
Table 138. Suzhou Xinxie Biotechnology Co., Ltd. Latest Developments
Table 139. APExBIO Technology LLC Basic Information, CD34+ Cell Selection Equipment Manufacturing Base, Sales Area and Its Competitors
Table 140. APExBIO Technology LLC CD34+ Cell Selection Equipment Product Portfolios and Specifications
Table 141. APExBIO Technology LLC CD34+ Cell Selection Equipment Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 142. APExBIO Technology LLC Main Business
Table 143. APExBIO Technology LLC Latest Developments
LIST OF FIGURES
Figure 1. Picture of CD34+ Cell Selection Equipment
Figure 2. CD34+ Cell Selection Equipment Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global CD34+ Cell Selection Equipment Sales Growth Rate 2021-2032 (Units)
Figure 7. Global CD34+ Cell Selection Equipment Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. CD34+ Cell Selection Equipment Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. CD34+ Cell Selection Equipment Sales Market Share by Country/Region (2025)
Figure 10. CD34+ Cell Selection Equipment Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Column-Based Immunomagnetic Selection
Figure 12. Product Picture of Column-Free Immunomagnetic Selection
Figure 13. Product Picture of Buoyancy-Activated Microbubble Sorting
Figure 14. Global CD34+ Cell Selection Equipment Sales Market Share by Technology Route in 2026
Figure 15. Global CD34+ Cell Selection Equipment Revenue Market Share by Technology Route (2021-2026)
Figure 16. Product Picture of Closed Clinical System
Figure 17. Product Picture of Laboratory Selection Kit
Figure 18. Product Picture of Platform-Based Selection Instrument
Figure 19. Global CD34+ Cell Selection Equipment Sales Market Share by Product Delivery Form in 2026
Figure 20. Global CD34+ Cell Selection Equipment Revenue Market Share by Product Delivery Form (2021-2026)
Figure 21. Product Picture of Direct Positive Selection
Figure 22. Product Picture of Direct Negative Enrichment
Figure 23. Product Picture of Pre-Enrichment Followed By Positive Selection
Figure 24. Global CD34+ Cell Selection Equipment Sales Market Share by CD34+ Cell Acquisition Workflow in 2026
Figure 25. Global CD34+ Cell Selection Equipment Revenue Market Share by CD34+ Cell Acquisition Workflow (2021-2026)
Figure 26. CD34+ Cell Selection Equipment Consumed in Clinical Transplant Cell Preparation
Figure 27. Global CD34+ Cell Selection Equipment Market: Clinical Transplant Cell Preparation (2021-2026) & (Units)
Figure 28. CD34+ Cell Selection Equipment Consumed in Research-Use Cell Isolation
Figure 29. Global CD34+ Cell Selection Equipment Market: Research-Use Cell Isolation (2021-2026) & (Units)
Figure 30. CD34+ Cell Selection Equipment Consumed in Process Development And Translational Research
Figure 31. Global CD34+ Cell Selection Equipment Market: Process Development And Translational Research (2021-2026) & (Units)
Figure 32. Global CD34+ Cell Selection Equipment Sale Market Share by Application (2025)
Figure 33. Global CD34+ Cell Selection Equipment Revenue Market Share by Application in 2025
Figure 34. CD34+ Cell Selection Equipment Sales by Company in 2025 (Units)
Figure 35. Global CD34+ Cell Selection Equipment Sales Market Share by Company in 2025
Figure 36. CD34+ Cell Selection Equipment Revenue by Company in 2025 ($ millions)
Figure 37. Global CD34+ Cell Selection Equipment Revenue Market Share by Company in 2025
Figure 38. Global CD34+ Cell Selection Equipment Sales Market Share by Geographic Region (2021-2026)
Figure 39. Global CD34+ Cell Selection Equipment Revenue Market Share by Geographic Region in 2025
Figure 40. Americas CD34+ Cell Selection Equipment Sales 2021-2026 (Units)
Figure 41. Americas CD34+ Cell Selection Equipment Revenue 2021-2026 ($ millions)
Figure 42. APAC CD34+ Cell Selection Equipment Sales 2021-2026 (Units)
Figure 43. APAC CD34+ Cell Selection Equipment Revenue 2021-2026 ($ millions)
Figure 44. Europe CD34+ Cell Selection Equipment Sales 2021-2026 (Units)
Figure 45. Europe CD34+ Cell Selection Equipment Revenue 2021-2026 ($ millions)
Figure 46. Middle East & Africa CD34+ Cell Selection Equipment Sales 2021-2026 (Units)
Figure 47. Middle East & Africa CD34+ Cell Selection Equipment Revenue 2021-2026 ($ millions)
Figure 48. Americas CD34+ Cell Selection Equipment Sales Market Share by Country in 2025
Figure 49. Americas CD34+ Cell Selection Equipment Revenue Market Share by Country (2021-2026)
Figure 50. Americas CD34+ Cell Selection Equipment Sales Market Share by Technology Route (2021-2026)
Figure 51. Americas CD34+ Cell Selection Equipment Sales Market Share by Application (2021-2026)
Figure 52. United States CD34+ Cell Selection Equipment Revenue Growth 2021-2026 ($ millions)
Figure 53. Canada CD34+ Cell Selection Equipment Revenue Growth 2021-2026 ($ millions)
Figure 54. Mexico CD34+ Cell Selection Equipment Revenue Growth 2021-2026 ($ millions)
Figure 55. Brazil CD34+ Cell Selection Equipment Revenue Growth 2021-2026 ($ millions)
Figure 56. APAC CD34+ Cell Selection Equipment Sales Market Share by Region in 2025
Figure 57. APAC CD34+ Cell Selection Equipment Revenue Market Share by Region (2021-2026)
Figure 58. APAC CD34+ Cell Selection Equipment Sales Market Share by Technology Route (2021-2026)
Figure 59. APAC CD34+ Cell Selection Equipment Sales Market Share by Application (2021-2026)
Figure 60. China CD34+ Cell Selection Equipment Revenue Growth 2021-2026 ($ millions)
Figure 61. Japan CD34+ Cell Selection Equipment Revenue Growth 2021-2026 ($ millions)
Figure 62. South Korea CD34+ Cell Selection Equipment Revenue Growth 2021-2026 ($ millions)
Figure 63. Southeast Asia CD34+ Cell Selection Equipment Revenue Growth 2021-2026 ($ millions)
Figure 64. India CD34+ Cell Selection Equipment Revenue Growth 2021-2026 ($ millions)
Figure 65. Australia CD34+ Cell Selection Equipment Revenue Growth 2021-2026 ($ millions)
Figure 66. China Taiwan CD34+ Cell Selection Equipment Revenue Growth 2021-2026 ($ millions)
Figure 67. Europe CD34+ Cell Selection Equipment Sales Market Share by Country in 2025
Figure 68. Europe CD34+ Cell Selection Equipment Revenue Market Share by Country (2021-2026)
Figure 69. Europe CD34+ Cell Selection Equipment Sales Market Share by Technology Route (2021-2026)
Figure 70. Europe CD34+ Cell Selection Equipment Sales Market Share by Application (2021-2026)
Figure 71. Germany CD34+ Cell Selection Equipment Revenue Growth 2021-2026 ($ millions)
Figure 72. France CD34+ Cell Selection Equipment Revenue Growth 2021-2026 ($ millions)
Figure 73. UK CD34+ Cell Selection Equipment Revenue Growth 2021-2026 ($ millions)
Figure 74. Italy CD34+ Cell Selection Equipment Revenue Growth 2021-2026 ($ millions)
Figure 75. Russia CD34+ Cell Selection Equipment Revenue Growth 2021-2026 ($ millions)
Figure 76. Middle East & Africa CD34+ Cell Selection Equipment Sales Market Share by Country (2021-2026)
Figure 77. Middle East & Africa CD34+ Cell Selection Equipment Sales Market Share by Technology Route (2021-2026)
Figure 78. Middle East & Africa CD34+ Cell Selection Equipment Sales Market Share by Application (2021-2026)
Figure 79. Egypt CD34+ Cell Selection Equipment Revenue Growth 2021-2026 ($ millions)
Figure 80. South Africa CD34+ Cell Selection Equipment Revenue Growth 2021-2026 ($ millions)
Figure 81. Israel CD34+ Cell Selection Equipment Revenue Growth 2021-2026 ($ millions)
Figure 82. Turkey CD34+ Cell Selection Equipment Revenue Growth 2021-2026 ($ millions)
Figure 83. GCC Countries CD34+ Cell Selection Equipment Revenue Growth 2021-2026 ($ millions)
Figure 84. Manufacturing Cost Structure Analysis of CD34+ Cell Selection Equipment in 2026
Figure 85. Manufacturing Process Analysis of CD34+ Cell Selection Equipment
Figure 86. Industry Chain Structure of CD34+ Cell Selection Equipment
Figure 87. Channels of Distribution
Figure 88. Global CD34+ Cell Selection Equipment Sales Market Forecast by Region (2027-2032)
Figure 89. Global CD34+ Cell Selection Equipment Revenue Market Share Forecast by Region (2027-2032)
Figure 90. Global CD34+ Cell Selection Equipment Sales Market Share Forecast by Technology Route (2027-2032)
Figure 91. Global CD34+ Cell Selection Equipment Revenue Market Share Forecast by Technology Route (2027-2032)
Figure 92. Global CD34+ Cell Selection Equipment Sales Market Share Forecast by Application (2027-2032)
Figure 93. Global CD34+ Cell Selection Equipment Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of CD34+ Cell Selection Equipment
Figure 2. CD34+ Cell Selection Equipment Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global CD34+ Cell Selection Equipment Sales Growth Rate 2021-2032 (Units)
Figure 7. Global CD34+ Cell Selection Equipment Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. CD34+ Cell Selection Equipment Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. CD34+ Cell Selection Equipment Sales Market Share by Country/Region (2025)
Figure 10. CD34+ Cell Selection Equipment Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Column-Based Immunomagnetic Selection
Figure 12. Product Picture of Column-Free Immunomagnetic Selection
Figure 13. Product Picture of Buoyancy-Activated Microbubble Sorting
Figure 14. Global CD34+ Cell Selection Equipment Sales Market Share by Technology Route in 2026
Figure 15. Global CD34+ Cell Selection Equipment Revenue Market Share by Technology Route (2021-2026)
Figure 16. Product Picture of Closed Clinical System
Figure 17. Product Picture of Laboratory Selection Kit
Figure 18. Product Picture of Platform-Based Selection Instrument
Figure 19. Global CD34+ Cell Selection Equipment Sales Market Share by Product Delivery Form in 2026
Figure 20. Global CD34+ Cell Selection Equipment Revenue Market Share by Product Delivery Form (2021-2026)
Figure 21. Product Picture of Direct Positive Selection
Figure 22. Product Picture of Direct Negative Enrichment
Figure 23. Product Picture of Pre-Enrichment Followed By Positive Selection
Figure 24. Global CD34+ Cell Selection Equipment Sales Market Share by CD34+ Cell Acquisition Workflow in 2026
Figure 25. Global CD34+ Cell Selection Equipment Revenue Market Share by CD34+ Cell Acquisition Workflow (2021-2026)
Figure 26. CD34+ Cell Selection Equipment Consumed in Clinical Transplant Cell Preparation
Figure 27. Global CD34+ Cell Selection Equipment Market: Clinical Transplant Cell Preparation (2021-2026) & (Units)
Figure 28. CD34+ Cell Selection Equipment Consumed in Research-Use Cell Isolation
Figure 29. Global CD34+ Cell Selection Equipment Market: Research-Use Cell Isolation (2021-2026) & (Units)
Figure 30. CD34+ Cell Selection Equipment Consumed in Process Development And Translational Research
Figure 31. Global CD34+ Cell Selection Equipment Market: Process Development And Translational Research (2021-2026) & (Units)
Figure 32. Global CD34+ Cell Selection Equipment Sale Market Share by Application (2025)
Figure 33. Global CD34+ Cell Selection Equipment Revenue Market Share by Application in 2025
Figure 34. CD34+ Cell Selection Equipment Sales by Company in 2025 (Units)
Figure 35. Global CD34+ Cell Selection Equipment Sales Market Share by Company in 2025
Figure 36. CD34+ Cell Selection Equipment Revenue by Company in 2025 ($ millions)
Figure 37. Global CD34+ Cell Selection Equipment Revenue Market Share by Company in 2025
Figure 38. Global CD34+ Cell Selection Equipment Sales Market Share by Geographic Region (2021-2026)
Figure 39. Global CD34+ Cell Selection Equipment Revenue Market Share by Geographic Region in 2025
Figure 40. Americas CD34+ Cell Selection Equipment Sales 2021-2026 (Units)
Figure 41. Americas CD34+ Cell Selection Equipment Revenue 2021-2026 ($ millions)
Figure 42. APAC CD34+ Cell Selection Equipment Sales 2021-2026 (Units)
Figure 43. APAC CD34+ Cell Selection Equipment Revenue 2021-2026 ($ millions)
Figure 44. Europe CD34+ Cell Selection Equipment Sales 2021-2026 (Units)
Figure 45. Europe CD34+ Cell Selection Equipment Revenue 2021-2026 ($ millions)
Figure 46. Middle East & Africa CD34+ Cell Selection Equipment Sales 2021-2026 (Units)
Figure 47. Middle East & Africa CD34+ Cell Selection Equipment Revenue 2021-2026 ($ millions)
Figure 48. Americas CD34+ Cell Selection Equipment Sales Market Share by Country in 2025
Figure 49. Americas CD34+ Cell Selection Equipment Revenue Market Share by Country (2021-2026)
Figure 50. Americas CD34+ Cell Selection Equipment Sales Market Share by Technology Route (2021-2026)
Figure 51. Americas CD34+ Cell Selection Equipment Sales Market Share by Application (2021-2026)
Figure 52. United States CD34+ Cell Selection Equipment Revenue Growth 2021-2026 ($ millions)
Figure 53. Canada CD34+ Cell Selection Equipment Revenue Growth 2021-2026 ($ millions)
Figure 54. Mexico CD34+ Cell Selection Equipment Revenue Growth 2021-2026 ($ millions)
Figure 55. Brazil CD34+ Cell Selection Equipment Revenue Growth 2021-2026 ($ millions)
Figure 56. APAC CD34+ Cell Selection Equipment Sales Market Share by Region in 2025
Figure 57. APAC CD34+ Cell Selection Equipment Revenue Market Share by Region (2021-2026)
Figure 58. APAC CD34+ Cell Selection Equipment Sales Market Share by Technology Route (2021-2026)
Figure 59. APAC CD34+ Cell Selection Equipment Sales Market Share by Application (2021-2026)
Figure 60. China CD34+ Cell Selection Equipment Revenue Growth 2021-2026 ($ millions)
Figure 61. Japan CD34+ Cell Selection Equipment Revenue Growth 2021-2026 ($ millions)
Figure 62. South Korea CD34+ Cell Selection Equipment Revenue Growth 2021-2026 ($ millions)
Figure 63. Southeast Asia CD34+ Cell Selection Equipment Revenue Growth 2021-2026 ($ millions)
Figure 64. India CD34+ Cell Selection Equipment Revenue Growth 2021-2026 ($ millions)
Figure 65. Australia CD34+ Cell Selection Equipment Revenue Growth 2021-2026 ($ millions)
Figure 66. China Taiwan CD34+ Cell Selection Equipment Revenue Growth 2021-2026 ($ millions)
Figure 67. Europe CD34+ Cell Selection Equipment Sales Market Share by Country in 2025
Figure 68. Europe CD34+ Cell Selection Equipment Revenue Market Share by Country (2021-2026)
Figure 69. Europe CD34+ Cell Selection Equipment Sales Market Share by Technology Route (2021-2026)
Figure 70. Europe CD34+ Cell Selection Equipment Sales Market Share by Application (2021-2026)
Figure 71. Germany CD34+ Cell Selection Equipment Revenue Growth 2021-2026 ($ millions)
Figure 72. France CD34+ Cell Selection Equipment Revenue Growth 2021-2026 ($ millions)
Figure 73. UK CD34+ Cell Selection Equipment Revenue Growth 2021-2026 ($ millions)
Figure 74. Italy CD34+ Cell Selection Equipment Revenue Growth 2021-2026 ($ millions)
Figure 75. Russia CD34+ Cell Selection Equipment Revenue Growth 2021-2026 ($ millions)
Figure 76. Middle East & Africa CD34+ Cell Selection Equipment Sales Market Share by Country (2021-2026)
Figure 77. Middle East & Africa CD34+ Cell Selection Equipment Sales Market Share by Technology Route (2021-2026)
Figure 78. Middle East & Africa CD34+ Cell Selection Equipment Sales Market Share by Application (2021-2026)
Figure 79. Egypt CD34+ Cell Selection Equipment Revenue Growth 2021-2026 ($ millions)
Figure 80. South Africa CD34+ Cell Selection Equipment Revenue Growth 2021-2026 ($ millions)
Figure 81. Israel CD34+ Cell Selection Equipment Revenue Growth 2021-2026 ($ millions)
Figure 82. Turkey CD34+ Cell Selection Equipment Revenue Growth 2021-2026 ($ millions)
Figure 83. GCC Countries CD34+ Cell Selection Equipment Revenue Growth 2021-2026 ($ millions)
Figure 84. Manufacturing Cost Structure Analysis of CD34+ Cell Selection Equipment in 2026
Figure 85. Manufacturing Process Analysis of CD34+ Cell Selection Equipment
Figure 86. Industry Chain Structure of CD34+ Cell Selection Equipment
Figure 87. Channels of Distribution
Figure 88. Global CD34+ Cell Selection Equipment Sales Market Forecast by Region (2027-2032)
Figure 89. Global CD34+ Cell Selection Equipment Revenue Market Share Forecast by Region (2027-2032)
Figure 90. Global CD34+ Cell Selection Equipment Sales Market Share Forecast by Technology Route (2027-2032)
Figure 91. Global CD34+ Cell Selection Equipment Revenue Market Share Forecast by Technology Route (2027-2032)
Figure 92. Global CD34+ Cell Selection Equipment Sales Market Share Forecast by Application (2027-2032)
Figure 93. Global CD34+ Cell Selection Equipment Revenue Market Share Forecast by Application (2027-2032)
